12 articles for T Ullrich
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administration.

Novartis Institutes For Biomedical Research
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.

National Institute of Diabetes and Digestive and Kidney Diseases
Derivatives of 17-(2-methylallyl)-substituted noroxymorphone: variation of the delta address and its effects on affinity and selectivity for the delta opioid receptor.

Niddk
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva.

Novartis Institutes For Biomedical Research
Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.

Novartis Institutes For Biomedical Research
Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptor.

Vienna University of Technology
Human plasma kallikrein inhibitors

Biocryst Pharmaceuticals
MAP kinase modulators and uses thereof

Columbia University
SHMT inhibitors

The Trustees of Princeton University
FXR (NR1H4) modulating compounds

Gilead Sciences
Antidiabetic bicyclic compounds

Merch Sharp & Dohne Corp. Rahway
Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents.

Argonne National Laboratory